1. Home
  2. FTLF vs KLRS Comparison

FTLF vs KLRS Comparison

Compare FTLF & KLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FitLife Brands Inc.

FTLF

FitLife Brands Inc.

HOLD

Current Price

$9.31

Market Cap

134.1M

Sector

Health Care

ML Signal

HOLD

Logo Kalaris Therapeutics Inc.

KLRS

Kalaris Therapeutics Inc.

HOLD

Current Price

$5.55

Market Cap

144.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTLF
KLRS
Founded
2005
2019
Country
United States
United States
Employees
N/A
20
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.1M
144.9M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
FTLF
KLRS
Price
$9.31
$5.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$21.50
$19.00
AVG Volume (30 Days)
37.0K
74.4K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.63
N/A
Revenue
$21,744,000.00
N/A
Revenue This Year
$45.76
N/A
Revenue Next Year
$5.10
N/A
P/E Ratio
$14.91
N/A
Revenue Growth
11.52
N/A
52 Week Low
$8.67
$2.14
52 Week High
$20.98
$11.88

Technical Indicators

Market Signals
Indicator
FTLF
KLRS
Relative Strength Index (RSI) 31.17 36.83
Support Level $8.67 $5.26
Resistance Level $15.34 $7.18
Average True Range (ATR) 0.57 0.47
MACD 0.15 0.04
Stochastic Oscillator 45.45 11.90

Price Performance

Historical Comparison
FTLF
KLRS

About FTLF FitLife Brands Inc.

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

About KLRS Kalaris Therapeutics Inc.

Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.

Share on Social Networks: